Compare MAMA & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAMA | RXST |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 513.1M |
| IPO Year | N/A | 2021 |
| Metric | MAMA | RXST |
|---|---|---|
| Price | $13.46 | $12.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 11 |
| Target Price | ★ $17.00 | $11.30 |
| AVG Volume (30 Days) | 499.5K | ★ 850.9K |
| Earning Date | 12-08-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.91 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $151,312,000.00 | $142,085,000.00 |
| Revenue This Year | $35.43 | N/A |
| Revenue Next Year | $28.82 | $4.18 |
| P/E Ratio | $111.49 | ★ N/A |
| Revenue Growth | ★ 29.92 | 10.75 |
| 52 Week Low | $5.50 | $6.32 |
| 52 Week High | $14.50 | $39.37 |
| Indicator | MAMA | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 68.14 | 67.06 |
| Support Level | $11.04 | $11.84 |
| Resistance Level | $14.50 | $13.22 |
| Average True Range (ATR) | 0.74 | 0.65 |
| MACD | 0.23 | 0.05 |
| Stochastic Oscillator | 74.23 | 77.33 |
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.